Anixa Biosciences, Inc.
ANIXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $102.20M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.32$5.46
- Volume (live)
- -
- Avg. volume (3M)
- 287.04K
Anixa Biosciences (ANIX) Stock Price & Financial Analysis
Anixa Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.74 - $3.14 |
|---|---|
| 52-Week High | $5.46 |
| 52-Week Low | $2.32 |
| Open | $2.80 |
| Volume (last close) | 326.68K |
| Average Volume (3M) | 287.04K |
| 50-Day MA | $3.02 |
|---|---|
| 200-Day MA | $2.98 |
| 1-Year Change | −33.49% |
| Market Cap | 102.20M |
|---|---|
| Shares Outstanding | 34.18M |
| Price to Book (P/B) | 7.74 |
| EV/EBITDA | -8.76 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Anixa Biosciences at a Glance
As of the Oct 23, 2026 close, Anixa Biosciences (ANIX) has a market capitalization of $102.20M.
As of its latest reported balance sheet, it holds $1.40M in cash and securities against $174.00K of debt, a net cash position of $1.22M.
Anixa Biosciences does not currently pay a dividend.
The share price is down 33.5% over the past year. At $2.99 (the Oct 23, 2026 close) it sits within its 52-week range of $2.32 to $5.46, above its 200-day moving average of $2.98.
Frequently Asked Questions About Anixa Biosciences
What is the current stock price for ANIX?
As of the Oct 23, 2026 close, ANIX stock trades at $2.99. The 52-week range is $2.32–$5.46, with a day range of $2.74–$3.14.
What is the P/E ratio for ANIX?
The P/E ratio (Price-to-Earnings) for ANIX is shown in the Key Statistics section. This valuation metric helps compare Anixa Biosciences, Inc. to industry peers.
Does ANIX pay dividends?
Anixa Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANIX?
Analyst ratings and recommendations for ANIX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ANIX?
As of the Oct 23, 2026 close, Anixa Biosciences's market capitalization is $102.2M, classifying it as a micro-cap company. Anixa Biosciences operates in the Healthcare sector within the Biotechnology industry.